Literature DB >> 24703333

Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome.

Karen E Rabenau1, Michelle Dolan2, Sophia Yohe3, Celalettin Ustun4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24703333     DOI: 10.1016/j.cancergen.2014.02.006

Source DB:  PubMed          Journal:  Cancer Genet


× No keyword cloud information.
  4 in total

1.  Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Authors:  Ryota Kanemaru; Fumiyuki Takahashi; Motoyasu Kato; Yoichiro Mitsuishi; Ken Tajima; Hiroaki Ihara; Moulid Hidayat; Aditya Wirawan; Yoshika Koinuma; Daisuke Hayakawa; Shigehiro Yagishita; Ryo Ko; Tadashi Sato; Norihiro Harada; Yuzo Kodama; Fariz Nurwidya; Shinichi Sasaki; Shin-Ichiro Niwa; Kazuhisa Takahashi
Journal:  Lung       Date:  2018-06-20       Impact factor: 2.584

2.  Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

Authors:  Celalettin Ustun; Elizabeth L Courville; Todd DeFor; Michelle Dolan; Nicole Randall; Sophia Yohe; Nelli Bejanyan; Erica Warlick; Claudio Brunstein; Daniel J Weisdorf; Michael A Linden
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-10       Impact factor: 5.742

3.  Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis.

Authors:  Fernanda Ferreira Cruz; Lucas Felipe Bastos Horta; Lígia de Albuquerque Maia; Miquéias Lopes-Pacheco; André Benedito da Silva; Marcelo Marco Morales; Cassiano Felippe Gonçalves-de-Albuquerque; Christina Maeda Takiya; Hugo Caire de Castro-Faria-Neto; Patricia Rieken Macedo Rocco
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

4.  The Yin and Yang of Tyrosine Kinase Inhibition During Experimental Polymicrobial Sepsis.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Ina Rohwedder; Adriana Ribeiro Silva; Alessandra Silveira Ferreira; Angela R M Kurz; Céline Cougoule; Sarah Klapproth; Tanja Eggersmann; Johnatas D Silva; Gisele Pena de Oliveira; Vera Luiza Capelozzi; Gabriel Gutfilen Schlesinger; Edlaine Rijo Costa; Rita de Cassia Elias Estrela Marins; Attila Mócsai; Isabelle Maridonneau-Parini; Barbara Walzog; Patricia Rieken Macedo Rocco; Markus Sperandio; Hugo Caire de Castro-Faria-Neto
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.